Pharmacokinetic considerations in the development of peptide-based imaging agents

Quarterly Journal of Nuclear Medicine

Volumn 41, Issue 2, 1997, Pages 111-118

  Lister James, J ^a   Moyer, B R ^a   Dean, R T ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Peptides; Pharmacokinetics; Scintigraphic Imaging

Indexed keywords

OCTREOTIDE[3 TYROSINE]; P28 TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; PROTEIN DEGRADATION; SCINTISCANNING;

ANIMALS; HUMANS; MOLECULAR WEIGHT; PEPTIDES; RADIOPHARMACEUTICALS;

EID: 0030975625     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)